Cutler Group LP Abb Vie Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $3.02 Million - $3.44 Million	-18,900 Reduced 75.0%	6,300 $203,000
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $1 Million - $1.13 Million	7,300 Added 40.78%	25,200 $183,000
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $2.52 Million - $2.92 Million	-18,900 Reduced 51.36%	17,900 $32,000
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $4.73 Million - $5.89 Million	35,700 Added 3245.45%	36,800 $25,000
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $4.82 Million - $5.55 Million	-33,300 Reduced 96.8%	1,100 $3,000
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $2.92 Million - $3.5 Million	-21,100 Reduced 38.02%	34,400 $21,000
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $7.07 Million - $8.11 Million	-52,700 Reduced 48.71%	55,500 $127,000
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $10.9 Million - $13.9 Million	-79,300 Reduced 42.29%	108,200 $592,000
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $14.1 Million - $17.5 Million	106,800 Added 132.34%	187,500 $2.82 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $3.27 Million - $4.13 Million	30,400 Added 60.44%	80,700 $1.18 Million
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $6.25 Million - $7.09 Million	-58,700 Reduced 53.85%	50,300 $130,000
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $7.7 Million - $8.58 Million	73,200 Added 204.47%	109,000 $189,000
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $7.98 Million - $8.78 Million	-78,000 Reduced 68.54%	35,800 $105,000
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $8.42 Million - $11.4 Million	104,600 Added 1136.96%	113,800 $530,000
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $601,370 - $705,810	-7,000 Reduced 43.21%	9,200 $34,000
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $454,894 - $608,716	-6,200 Reduced 27.68%	16,200 $171,000
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $77,400 - $117,348	-1,200 Reduced 5.08%	22,400 $21,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $980,967 - $1.23 Million	-13,600 Reduced 36.56%	23,600 $285,000
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $4.51 Million - $5.42 Million	-71,600 Reduced 65.81%	37,200 $153,000
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $3.78 Million - $4.83 Million	57,500 Added 112.09%	108,800 $117,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $1.47 Million - $1.73 Million	19,000 Added 58.82%	51,300 $201,000
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $778,500 - $960,100	10,000 Added 44.84%	32,300 $494,000
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $978,010 - $1.09 Million	-11,000 Reduced 33.03%	22,300 $440,000
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $3.08 Million - $3.64 Million	-34,300 Reduced 50.74%	33,300 $518,000
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $1.64 Million - $2.19 Million	17,800 Added 35.74%	67,600 $624,000
Q4 2017 Jan 17, 2018	SELL	$89.56 - $98.21 $4.42 Million - $4.85 Million	-49,400 Reduced 49.8%	49,800 $993,000
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $6.93 Million - $8.85 Million	99,200	99,200 $1.23 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account